Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China
· Delayed Price · Currency is CNY 41.63
-0.80 (-1.89%)
Mar 9, 2026, 3:00 PM CST
SHA:600211 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 981.2 | 1,051 | 800.91 | 369.84 | 208.94 | 418.1 | Upgrade
|
| Depreciation & Amortization | 75.1 | 75.1 | 68.05 | 69.24 | 81.45 | 77.63 | Upgrade
|
| Other Amortization | 0.74 | 0.74 | 1.01 | 1.55 | 0.68 | 0.32 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.9 | -1.9 | -0.34 | 0.23 | 0.04 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 190.38 | 218.62 | 458.19 | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | 3.88 | 3.88 | 170.09 | 7.14 | -146.47 | -0.98 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.6 | 0.6 | 0.04 | -0.51 | -1.39 | 0.39 | Upgrade
|
| Other Operating Activities | 23.26 | -12.63 | -5.68 | 81.94 | 15.93 | 3.87 | Upgrade
|
| Change in Accounts Receivable | 98.83 | 98.83 | -237.89 | 22.82 | -317.1 | -21.7 | Upgrade
|
| Change in Inventory | -22.56 | -22.56 | -16.56 | -18.87 | -67.2 | 3.32 | Upgrade
|
| Change in Accounts Payable | -163.73 | -163.73 | 147.4 | 38.73 | 164.85 | 28.01 | Upgrade
|
| Change in Other Net Operating Assets | 2.02 | 2.02 | 1.87 | 52.43 | -1.62 | -78.25 | Upgrade
|
| Operating Cash Flow | 960.59 | 994.79 | 1,063 | 837.38 | 366.53 | 428.17 | Upgrade
|
| Operating Cash Flow Growth | -6.50% | -6.45% | 26.99% | 128.46% | -14.39% | -12.55% | Upgrade
|
| Capital Expenditures | -34.7 | -37.6 | -21.69 | -101.96 | -425.58 | -221.29 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.73 | 2.78 | 0.54 | 0.11 | 16.78 | 0.01 | Upgrade
|
| Investment in Securities | -557.75 | 367.91 | -829.46 | -471.69 | -334.97 | 280 | Upgrade
|
| Other Investing Activities | 172.57 | 21.39 | 18.72 | 12.3 | 2.97 | 10.44 | Upgrade
|
| Investing Cash Flow | -417.15 | 354.49 | -831.88 | -561.25 | -740.8 | 69.16 | Upgrade
|
| Short-Term Debt Issued | - | 533.5 | 699.51 | 485.73 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 576.54 | 10.4 | Upgrade
|
| Total Debt Issued | 916.18 | 533.5 | 699.51 | 485.73 | 576.54 | 10.4 | Upgrade
|
| Short-Term Debt Repaid | - | -760.97 | -685.73 | -534.27 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.93 | -1.65 | -3.56 | -56.08 | - | Upgrade
|
| Total Debt Repaid | -387.14 | -761.9 | -687.39 | -537.82 | -56.08 | - | Upgrade
|
| Net Debt Issued (Repaid) | 529.04 | -228.4 | 12.13 | -52.09 | 520.46 | 10.4 | Upgrade
|
| Common Dividends Paid | -596.09 | -494.41 | -494.47 | -98.18 | -132.49 | -188.83 | Upgrade
|
| Other Financing Activities | -11.39 | -10.18 | -1.34 | 4.9 | -11.3 | - | Upgrade
|
| Financing Cash Flow | -78.44 | -732.99 | -483.69 | -145.37 | 376.67 | -178.43 | Upgrade
|
| Foreign Exchange Rate Adjustments | 13.03 | 7.44 | 7.04 | 40.11 | -14.42 | -27.87 | Upgrade
|
| Net Cash Flow | 478.03 | 623.72 | -245.11 | 170.87 | -12.02 | 291.03 | Upgrade
|
| Free Cash Flow | 925.89 | 957.19 | 1,042 | 735.41 | -59.05 | 206.87 | Upgrade
|
| Free Cash Flow Growth | -8.38% | -8.12% | 41.65% | - | - | -53.05% | Upgrade
|
| Free Cash Flow Margin | 34.03% | 34.10% | 33.24% | 28.79% | -2.76% | 15.07% | Upgrade
|
| Free Cash Flow Per Share | 2.87 | 2.97 | 3.23 | 2.28 | -0.18 | 0.64 | Upgrade
|
| Cash Interest Paid | 9.64 | 9.64 | - | - | - | - | Upgrade
|
| Cash Income Tax Paid | 387.58 | 500.59 | 443.23 | 272.41 | 274.84 | 185.36 | Upgrade
|
| Levered Free Cash Flow | 528.49 | 483.26 | 585.86 | 456.08 | -60.38 | 76.87 | Upgrade
|
| Unlevered Free Cash Flow | 530.03 | 489.19 | 593.11 | 465.06 | -57.68 | 77.53 | Upgrade
|
| Change in Working Capital | -122.3 | -122.3 | -161.05 | 89.34 | -250.83 | -71.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.